xmlns:atom="http://www.w3.org/2005/Atom" xmlns:atom="http://www.w3.org/2005/Atom"

SCHEDULE 3 E+WINFORMATION TO BE INCLUDED IN AN APPLICATION FOR CONSENT TO MARKET GENETICALLY MODIFIED ORGANISMS

Part II E+WADDITIONAL RELEVANT INFORMATION

9.  The measures to be taken in the event of the escape of the organisms in the product or misuse of the product.E+W

10.  Specific instructions or recommendations for storage and handling of the product.E+W

11.  Specific instructions for carrying out monitoring and reporting to the applicant and, if required, the National Assembly for Wales, which are consistent with Part C of Annex VII of the Deliberate Release Directive.E+W

12.  The proposed restrictions in the approved use of the genetically modified organism, such as where the product may be used and for what purposes.E+W

13.  The proposed packaging.E+W

14.  The estimated product in and/or imports to the Community.E+W

15.  Any proposed additional labelling, which may include, at least in summarised form, the information referred to in paragraphs 4 and 5 of Part I of this Schedule, or paragraphs 9 to 12 of this Part.E+W